Chemical genetics screen identifies COPB2 tool compounds that alters ER stress response and induces RTK dysregulation in lung cancer cells.

[1]  V. Wong,et al.  Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches , 2021, Oncogene.

[2]  Nikolina Radulovich,et al.  A drug discovery platform to identify compounds that inhibit EGFR triple mutants , 2020, Nature Chemical Biology.

[3]  S. Hariharan,et al.  A reference library for assigning protein subcellular localizations by image-based machine learning , 2020, The Journal of cell biology.

[4]  B. Haibe-Kains,et al.  Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer , 2019, Clinical Cancer Research.

[5]  P. Jänne,et al.  Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor. , 2019, Cancer discovery.

[6]  O. Wang,et al.  COPB2 is up‐regulated in breast cancer and plays a vital role in the metastasis via N‐cadherin and Vimentin , 2019, Journal of cellular and molecular medicine.

[7]  Qi-hua He,et al.  COPI-Mediated Nuclear Translocation of EGFRvIII Promotes STAT3 Phosphorylation and PKM2 Nuclear Localization , 2019, International journal of biological sciences.

[8]  S. Digumarthy,et al.  Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion. , 2018, Cancer discovery.

[9]  Abhijit A. Patel,et al.  Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors. , 2018, Cancer research.

[10]  M. Steinmetz,et al.  CLASP Suppresses Microtubule Catastrophes through a Single TOG Domain , 2018, Developmental cell.

[11]  Anne E Carpenter,et al.  CellProfiler 3.0: Next-generation image processing for biology , 2018, PLoS biology.

[12]  Shu Yang,et al.  COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  G. Christofori,et al.  PGE2 mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells , 2018, Oncotarget.

[14]  Ying Cheng,et al.  Osimertinib in Untreated EGFR‐Mutated Advanced Non–Small‐Cell Lung Cancer , 2018, The New England journal of medicine.

[15]  Ryohei Katayama,et al.  Targeting the Golgi apparatus to overcome acquired resistance of non-small cell lung cancer cells to EGFR tyrosine kinase inhibitors , 2017, Oncotarget.

[16]  Min Wang,et al.  COPB2 suppresses cell proliferation and induces cell cycle arrest in human colon cancer by regulating cell cycle-related proteins , 2017, Experimental and therapeutic medicine.

[17]  Max A. Horlbeck,et al.  Combined CRISPRi/a-Based Chemical Genetic Screens Reveal that Rigosertib Is a Microtubule-Destabilizing Agent , 2017, Molecular cell.

[18]  K. Sund,et al.  Copb2 is essential for embryogenesis and hypomorphic mutations cause human microcephaly , 2017, bioRxiv.

[19]  Jun Guo,et al.  The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex. , 2017, Nature chemical biology.

[20]  M. Tyers,et al.  A High-Resolution Genome-Wide CRISPR/Cas9 Viability Screen Reveals Structural Features and Contextual Diversity of the Human Cell-Essential Proteome , 2017, Molecular and Cellular Biology.

[21]  Jennifer E. Golden,et al.  Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells. , 2016, Nature chemical biology.

[22]  Roger J. Davis,et al.  Cell Signaling and Stress Responses. , 2016, Cold Spring Harbor perspectives in biology.

[23]  Weihong Ding,et al.  COPB2 Is Upregulated in Prostate Cancer and Regulates PC-3 Cell Proliferation, Cell Cycle, and Apoptosis. , 2016, Archives of medical research.

[24]  S. Dan,et al.  M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers. , 2016, Cancer research.

[25]  R. McCormack,et al.  EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII). , 2015, American journal of cancer research.

[26]  G. Poda,et al.  Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia , 2015, Nature chemical biology.

[27]  Aleksandra Markovets,et al.  Acquired EGFR C797S mediates resistance to AZD9291 in advanced non-small cell lung cancer harboring EGFR T790M , 2015, Nature Medicine.

[28]  Steven J. M. Jones,et al.  Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.

[29]  Ira Mellman,et al.  Endocytosis and cancer. , 2013, Cold Spring Harbor perspectives in biology.

[30]  I. Smal,et al.  End-binding proteins sensitize microtubules to the action of microtubule-targeting agents , 2013, Proceedings of the National Academy of Sciences.

[31]  T. Crombet,et al.  A view on EGFR-targeted therapies from the oncogene-addiction perspective , 2013, Front. Pharmacol..

[32]  Jennifer B Dennison,et al.  Abortive Autophagy Induces Endoplasmic Reticulum Stress and Cell Death in Cancer Cells , 2012, PloS one.

[33]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[34]  Shuichi Hirono,et al.  AMF-26, a Novel Inhibitor of the Golgi System, Targeting ADP-ribosylation Factor 1 (Arf1) with Potential for Cancer Therapy , 2011, The Journal of Biological Chemistry.

[35]  V. Calléja,et al.  A direct role for Met endocytosis in tumorigenesis , 2011, Nature Cell Biology.

[36]  M. Hung,et al.  COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport. , 2010, Biochemical and biophysical research communications.

[37]  J. Goldberg,et al.  Structure of Coatomer Cage Proteins and the Relationship among COPI, COPII, and Clathrin Vesicle Coats , 2010, Cell.

[38]  B. Ross,et al.  Molecular Imaging of N-linked Glycosylation Suggests Glycan Biosynthesis Is a Novel Target for Cancer Therapy , 2010, Clinical Cancer Research.

[39]  F. Ali-Osman,et al.  Cyclooxygenase-2 Is a Novel Transcriptional Target of the Nuclear EGFR-STAT3 and EGFRvIII-STAT3 Signaling Axes , 2010, Molecular Cancer Research.

[40]  Byung Min Chung,et al.  Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src@ , 2009, BMC Cell Biology.

[41]  F. De Vita,et al.  Anti‐epidermal growth factor receptor monoclonal antibodies in cancer therapy , 2009, Clinical and experimental immunology.

[42]  W. Xia,et al.  Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression , 2008, Nucleic acids research.

[43]  H. Freeze,et al.  Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells. , 2008, Cancer Research.

[44]  A. Citri,et al.  Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling , 2007, Oncogene.

[45]  Shinji Yamazaki,et al.  An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms. , 2007, Cancer research.

[46]  Sheng-Chieh Hsu,et al.  Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. , 2005, Cancer cell.

[47]  S. Gabriel,et al.  EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.

[48]  K. Makino,et al.  Nuclear localization of EGF receptor and its potential new role as a transcription factor , 2001, Nature Cell Biology.

[49]  J. Rothman,et al.  Budding from Golgi membranes requires the coatomer complex of non-clathrin coat proteins , 1993, Nature.

[50]  J. Rothman,et al.  Inhibition by brefeldin A of a Golgi membrane enzyme that catalyses exchange of guanine nucleotide bound to ARF , 1992, Nature.

[51]  J. Lippincott-Schwartz,et al.  Brefeldin A, a drug that blocks secretion, prevents the assembly of non-clathrin-coated buds on Golgi cisternae , 1991, Cell.

[52]  J. Rothman,et al.  'Coatomer': a cytosolic protein complex containing subunits of non-clathrin-coated Golgi transport vesicles , 1991, Nature.